Tags

Type your tag names separated by a space and hit enter

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med. 2021 01 07; 384(1):80-82.NEJM

Links

Publisher Full Text
ncbi.nlm.nih.gov
nejm.org
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Widge AT
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD alicia.widge@nih.gov.
Rouphael NG
Emory University School of Medicine, Decatur, GA.
Jackson LA
Kaiser Permanente Washington Health Research Institute, Seattle, WA.
Anderson EJ
Emory University School of Medicine, Decatur, GA.
Roberts PC
NIAID, Bethesda, MD.
Makhene M
NIAID, Bethesda, MD.
Chappell JD
Vanderbilt University Medical Center, Nashville, TN.
Denison MR
Vanderbilt University Medical Center, Nashville, TN.
Stevens LJ
Vanderbilt University Medical Center, Nashville, TN.
Pruijssers AJ
Vanderbilt University Medical Center, Nashville, TN.
McDermott AB
NIAID, Bethesda, MD.
Flach B
NIAID, Bethesda, MD.
Lin BC
NIAID, Bethesda, MD.
Doria-Rose NA
NIAID, Bethesda, MD.
O'Dell S
NIAID, Bethesda, MD.
Schmidt SD
NIAID, Bethesda, MD.
Neuzil KM
University of Maryland School of Medicine, Baltimore, MD.
Bennett H
Moderna, Cambridge, MA.
Leav B
Moderna, Cambridge, MA.
Makowski M
Emmes Company, Rockville, MD.
Albert J
Emmes Company, Rockville, MD.
Cross K
Emmes Company, Rockville, MD.
Edara VV
Emory University School of Medicine, Decatur, GA.
Floyd K
Emory University School of Medicine, Decatur, GA.
Suthar MS
Emory University School of Medicine, Decatur, GA.
Buchanan W
NIAID, Bethesda, MD.
Luke CJ
NIAID, Bethesda, MD.
Ledgerwood JE
NIAID, Bethesda, MD.
Mascola JR
NIAID, Bethesda, MD.
Graham BS
NIAID, Bethesda, MD.
Beigel JH
NIAID, Bethesda, MD.
mRNA-1273 Study Group
No affiliation info available

MeSH

2019-nCoV Vaccine mRNA-1273AdolescentAdultAgedAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesHumansImmunization, SecondaryMiddle AgedSARS-CoV-2Spike Glycoprotein, CoronavirusTh1 CellsYoung Adult

Pub Type(s)

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

33270381

Citation

Widge, Alicia T., et al. "Durability of Responses After SARS-CoV-2 mRNA-1273 Vaccination." The New England Journal of Medicine, vol. 384, no. 1, 2021, pp. 80-82.
Widge AT, Rouphael NG, Jackson LA, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. 2021;384(1):80-82.
Widge, A. T., Rouphael, N. G., Jackson, L. A., Anderson, E. J., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., McDermott, A. B., Flach, B., Lin, B. C., Doria-Rose, N. A., O'Dell, S., Schmidt, S. D., Neuzil, K. M., Bennett, H., Leav, B., ... Beigel, J. H. (2021). Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. The New England Journal of Medicine, 384(1), 80-82. https://doi.org/10.1056/NEJMc2032195
Widge AT, et al. Durability of Responses After SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. 2021 01 7;384(1):80-82. PubMed PMID: 33270381.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. AU - Widge,Alicia T, AU - Rouphael,Nadine G, AU - Jackson,Lisa A, AU - Anderson,Evan J, AU - Roberts,Paul C, AU - Makhene,Mamodikoe, AU - Chappell,James D, AU - Denison,Mark R, AU - Stevens,Laura J, AU - Pruijssers,Andrea J, AU - McDermott,Adrian B, AU - Flach,Britta, AU - Lin,Bob C, AU - Doria-Rose,Nicole A, AU - O'Dell,Sijy, AU - Schmidt,Stephen D, AU - Neuzil,Kathleen M, AU - Bennett,Hamilton, AU - Leav,Brett, AU - Makowski,Mat, AU - Albert,Jim, AU - Cross,Kaitlyn, AU - Edara,Venkata-Viswanadh, AU - Floyd,Katharine, AU - Suthar,Mehul S, AU - Buchanan,Wendy, AU - Luke,Catherine J, AU - Ledgerwood,Julie E, AU - Mascola,John R, AU - Graham,Barney S, AU - Beigel,John H, AU - ,, Y1 - 2020/12/03/ PY - 2020/12/4/pubmed PY - 2021/1/13/medline PY - 2020/12/3/entrez SP - 80 EP - 82 JF - The New England journal of medicine JO - N Engl J Med VL - 384 IS - 1 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/33270381/Durability_of_Responses_after_SARS_CoV_2_mRNA_1273_Vaccination_ L2 - https://www.nejm.org/doi/10.1056/NEJMc2032195?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -